T cell immune profile changes predict durable response to nivolumab-rituximab in treatment naïve FL Open Access

These authors contributed equally to the study

Primary results were presented in part at the 66^th Annual Meeting of the American Society of Hematology, San Diego, California, 7^th – 10^th of December 2024

Data sharing statement: Requests for nonidentifiable data with valid academic reasons as judged by the trial management group will be granted, with appropriate data sharing agreement, and should be addressed to the corresponding author. Data will be made available 3 months after publication for a period of 5 years after the publication. Individual participant data will not be shared.